Award recordCONTRACT

AMNEAL PHARMACEUTICALS OF NEW YORK, LLC

PIID 36E79724A0001· VA Staff Offices· NAC PHARMACEUTICALS (36E797)· 6505 · DRUGS AND BIOLOGICALS· FY2024· $0 net obligations· UEI LVEBAQTPN615· NY

Description

EXERCISE TWO MONTHS OF OPTION YEAR TWO

Base award description: BPA FOR SODIUM OXYBATE

First action · last action
2023-10-17 · 2025-10-15
Transactions
5
First transaction's obligation
$0
Base + all options value (sum of deltas)
$2,500,000
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
—
Offers received
1
SDVOSB flag on record
No
Parent IDV
36F79722D0161
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 5 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$1$0Base award · 2023-10-17 · this action $0 · running total $0Modification P00001 · 2024-04-10 · this action $0 · running total $0Modification P00002 · 2024-09-30 · this action $0 · running total $0Modification P00003 · 2024-12-09 · this action $0 · running total $0Modification P00004 · 2025-10-15 · this action $0 · running total $0
  • Base2023-10-17+$0= $0
  • Mod P000012024-04-10+$0= $0
  • Mod P000022024-09-30+$0= $0
  • Mod P000032024-12-09+$0= $0
  • Mod P000042025-10-15+$0= $0
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2023-10-17+$0$0BPA FOR SODIUM OXYBATE
Mod P00001· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2024-04-10+$0$0SODIUM OXYBATE PRICE CHANGE
Mod P00002· EXERCISE AN OPTION2024-09-30+$0$0EXERCISE OPTION YEAR 1
Mod P00003· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2024-12-09+$0$02025 PUBLIC LAW UPDATES
Mod P00004· EXERCISE AN OPTION2025-10-15+$0$0EXERCISE TWO MONTHS OF OPTION YEAR TWO

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI LVEBAQTPN615)

AwardOffice · PSC / listingNet obligationsFY
36E79726A0013NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS$0FY2026
36C26026F0059260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$319,399FY2026
36C26025F0044260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$173,089FY2025
36C26024F0050260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$185,400FY2024
36F79722D0161NAC FEDERAL SUPPLY SCHEDULE (36F797) · 6505 · DRUGS AND BIOLOGICALS$0FY2022
36E79719N0017NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS$100,295FY2019

Other recipients under 6505 from NAC PHARMACEUTICALS (36E797) (most recent first)

AwardRecipientOfficeNet obligationsFY
36E79726A0025CHIESI USA INCNAC PHARMACEUTICALS (36E797)$0FY2026
36E79726A0024NEUROTECH PHARMACEUTICALS, INCNAC PHARMACEUTICALS (36E797)$0FY2026
36E79726A0023TAKEDA PHARMACEUTICALS AMERICA, INC.NAC PHARMACEUTICALS (36E797)$0FY2026
36E79726D0041GOLDEN STATE MEDICAL SUPPLY, INC.NAC PHARMACEUTICALS (36E797)$0FY2026
36E79726A0022AURINIA PHARMA US INCNAC PHARMACEUTICALS (36E797)$0FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_IDV_36E79724A0001_3600 · retrieved 2026-09-26.